The Insight Partners today announced the release of a comprehensive new Cell and Gene Therapy Contract Development and Manufacturing Organization Market report, projecting significant expansion through 2031. This extensive study reveals how personalized medicine, artificial intelligence-driven manufacturing, and strategic global partnerships are redefining the Cell and Gene Therapy...

"Key Drivers Impacting Executive Summary Lentiviral Vector Market Size and Share During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 11.90%, primarily driven by the rising demand for gene and cell therapies, especially in the treatment of cancer and genetic disorders. The credible Lentiviral Vector Marketreport comprises of various segments linked to...

"Key Drivers Impacting Executive Summary Lentiviral Vector Market Size and Share During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 11.90%, primarily driven by the rising demand for gene and cell therapies, especially in the treatment of cancer and genetic disorders The credible Lentiviral Vector Marketreport comprises of various segments linked...

“According to a new report published by Introspective Market Research, titled, Viral Vector and Plasmid DNA Manufacturing Market by Vector Type, Workflow, Application, and End-User, The Global Viral Vector and Plasmid DNA Manufacturing Market Size Was Valued at USD 5.4 Billion in 2023 and is Projected to Reach USD 28.9 Billion by 2032, Growing at a CAGR of 20.9%.”...

Executive Summery This report presents a detailed overview of the Viral Vector Manufacturing Market, highlighting key insights into its market size, share, and growth during the forecast period, i.e., 2024-30. It explores emerging trends, competitive dynamics, and the core drivers reshaping the industry. Backed by solid data and expert analysis, the study offers...